Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Recent & Breaking News (NDAQ:TCRT)

ZIOPHARM Oncology Inc (ZIOP) Jumps 10.37% on September 5

Equities.com September 5, 2014

ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities

GlobeNewswire August 7, 2014

ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for Darinaparsin

GlobeNewswire July 31, 2014

ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update

GlobeNewswire July 22, 2014

Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma

PR Newswire June 27, 2014

ZIOPHARM Oncology to Present at the 9th Annual JMP Securities Healthcare Conference

GlobeNewswire June 18, 2014

ZIOPHARM Announces Oral Presentation Highlighting Ad-RTS-IL-12 Results Correlated With Reducing Cancer Stem Cells in the Brain at ASGCT 17th Annual Meeting

GlobeNewswire May 22, 2014

ZIOPHARM Reports First-Quarter 2014 Financial Results and Reviews Recent Activities

GlobeNewswire May 8, 2014

ZIOPHARM Presents Preclinical Data at AACR Annual Meeting Supporting Controlled DNA-based IL-12 Therapy for Brain Cancer

GlobeNewswire April 8, 2014

ZIOPHARM Oncology to Present at the 21st Annual Future Leaders in the Biotech Industry Conference

GlobeNewswire March 20, 2014

ZIOPHARM Reports Fourth-Quarter and Full-Year 2013 Financial Results and Reviews Recent Activities

GlobeNewswire March 3, 2014

Five Star Equities Issues New Research Reports on CBM, INVN, TQNT and ZIOP

Accesswire February 12, 2014

ZIOPHARM Oncology to Present at the 16th Annual BIO CEO & Investor Conference

Globe Newswire February 3, 2014

ZIOPHARM Oncology to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Globe Newswire January 8, 2014

ZIOPHARM Reports Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-12

Globe Newswire December 7, 2013

Top Gainers & Losers: InterOil Corporation, Geron Corporation, Amazon.com, ZIOPHARM Oncology Inc

Accesswire December 6, 2013

ZIOPHARM Announces Unanimous Recombinant DNA Advisory Committee (RAC) Approval for Phase 1 Study of Ad-RTS-IL-12 in Subjects With Recurrent or Progressive Glioblastoma

Globe Newswire December 6, 2013

ZIOPHARM Oncology to Present at the 25th Annual Piper Jaffray Healthcare Conference

Globe Newswire November 27, 2013

SIRI, ZIOP, PRKR and CLSN added to NASDAQ Active Stock Watch List at EPR

Accesswire October 24, 2013

ZIOPHARM Oncology Prices Public Offering of Common Stock

Globe Newswire October 24, 2013